Skip to main content
Profusa, Inc. logo

Profusa, Inc. — Investor Relations & Filings

Ticker · PFSA ISIN · US66718N1037 US Manufacturing
Filings indexed 252 across all filing types
Latest filing 2023-03-04 Annual Report
Country US United States of America
Listing US PFSA

About Profusa, Inc.

https://profusa.com/

Profusa, Inc. is a digital health and medical technology company that develops tissue-integrating biosensors for continuous monitoring of body chemistries. The company's core technology consists of highly miniaturized, injectable sensors designed to minimize the foreign body response, enabling long-term, real-time transmission of clinical-grade data. Its primary product, the Lumee™ Oxygen Platform, is a wireless system that continuously measures tissue oxygen levels. Profusa's solutions are aimed at advancing personalized medicine, telehealth, and remote patient monitoring for conditions such as chronic limb-threatening ischemia. The company's mission is to make the body's chemistry easily accessible to improve health and wellness.

Recent filings

Filing Released Lang Actions
ANNUAL REPORT
Annual Report FY 2022
2023-03-04 English
DEFA 14A
Regulatory Filings
2023-03-02 English
8-K
Regulatory Filings
2023-03-02 English
425 Filing
Regulatory Filings
2023-03-02 English
Regulatory Filings 2023
Regulatory Filings
2023-02-22 English
DEF 14A
Proxy Solicitation & Information Statement
2023-02-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.